View of Outcomes of Autologous Stem Cell Transplant for relapsed or refractory classic Hodgkin lymphoma in the era of PD-1 inhibitors

Return to Article Details Outcomes of Autologous Stem Cell Transplant for relapsed or refractory classic Hodgkin lymphoma in the era of PD-1 inhibitors Download Download PDF